Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07320638

TRIM25 in Septic Patients

Expression of Trim25 in Peripheral Blood Mononuclear Cells of Patients With Sepsis and Non-sepsis and Its Relationship With the Prognosis of Patients With Sepsis

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
65 (estimated)
Sponsor
Ruijin Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Sepsis is a life-threatening condition caused by the body's overwhelming response to infection, which can lead to organ damage and failure. The goal of this observational study is to better understand the underlying biological changes that occur in patients with sepsis compared to those who do not have the condition. We will collect peripheral blood samples from patients diagnosed with sepsis and from non-sepsis control participants. From these samples, we will isolate peripheral blood mononuclear cells (PBMCs) and serum. We will then analyze these components to measure the activity of specific genes and the levels of key inflammatory factors (cytokines). The information we gather will help researchers identify molecular and inflammatory markers associated with sepsis. This knowledge is crucial for developing new and more effective methods for diagnosing and treating this critical illness.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTGene and Inflammatory Marker Analysis in Sepsis1.Sepsis Group: 1. SOFA score \>=2; 2. Aged 18-70 years male and female; 3. Hospitalization. 2.Non-sepsis Group: (1) Healthy adults; (2) Aged 18-70 years male and female.

Timeline

Start date
2021-12-10
Primary completion
2026-06-01
Completion
2026-07-01
First posted
2026-01-06
Last updated
2026-01-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07320638. Inclusion in this directory is not an endorsement.